HB 1827 — An Act providing for medical assistance coverage and insurance coverage of screening, prevention and treatment measures for osteoporosis as a result of menopause.
Congress · introduced 2025-09-02
Latest action: — Referred to INSURANCE, Sept. 2, 2025
Sponsors
- Melissa L. Shusterman (D, PA-157) — sponsor · 2025-09-02
- Liz Hanbidge (D, PA-61) — cosponsor · 2025-09-02
- Carol Hill-Evans (D, PA-95) — cosponsor · 2025-09-02
- Nancy Guenst (D, PA-152) — cosponsor · 2025-09-02
- Benjamin V. Sanchez (D, PA-153) — cosponsor · 2025-09-02
- Kristine C. Howard (D, PA-167) — cosponsor · 2025-09-02
- Nikki Rivera (D, PA-96) — cosponsor · 2025-09-02
- Pat Gallagher (D, PA-173) — cosponsor · 2025-09-02
- Darisha K. Parker (D, PA-198) — cosponsor · 2025-09-02
Action timeline
- · house — Referred to INSURANCE, Sept. 2, 2025
Text versions
No text versions on file yet — same ingest as the action timeline populates these. Each version has direct links to the XML / HTML / PDF at govinfo.gov.
Bill text
Printer's No. 2252 · 8,744 characters · source document
Read the full text
PRINTER'S NO. 2252
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE BILL
No. 1827
Session of
2025
INTRODUCED BY SHUSTERMAN, HANBIDGE, HILL-EVANS, GUENST, SANCHEZ,
HOWARD, RIVERA AND GALLAGHER, AUGUST 27, 2025
REFERRED TO COMMITTEE ON INSURANCE, SEPTEMBER 2, 2025
AN ACT
1 Providing for medical assistance coverage and insurance coverage
2 of screening, prevention and treatment measures for
3 osteoporosis as a result of menopause.
4 The General Assembly of the Commonwealth of Pennsylvania
5 hereby enacts as follows:
6 Section 1. Short title.
7 This act shall be known and may be cited as the Earlier
8 Insurance Coverage for Osteoporosis Treatments Act.
9 Section 2. Legislative findings.
10 The General Assembly finds that:
11 (1) Many individuals experiencing menopause have a range
12 of signs and symptoms, which may include osteoporosis.
13 (2) Osteoporosis may occur during menopause as a result
14 of lower estrogen levels in the body.
15 (3) According to the Cleveland Clinic, throughout the
16 first five years of menopause, as much as 20% of bone loss
17 occurs.
18 (4) Although the average age of women entering menopause
1 in the United States is 51 years of age, bone density
2 screenings are recommended for women over 65 years of age.
3 (5) Due to the lack of bone density screenings earlier
4 in life, which would allow for more effective prevention and
5 treatment measures before osteoporosis is more advanced and
6 harder to treat, for most women, a bone fracture may be the
7 first sign of osteoporosis.
8 (6) Among individuals with osteoporosis, vertebral or
9 spine fractures, fractures in the forearm or wrist and hip
10 fractures are the most common.
11 (7) Bone fractures related to osteoporosis that occur in
12 the spine or hip areas are especially concerning, as
13 mortality rates for older adults who have experienced a hip
14 fracture are significantly higher than those of older adults
15 who have not experienced a hip fracture.
16 (8) Bone mineral density testing to measure the amount
17 of mineral in an individual's bones may be helpful in
18 screening for and diagnosing osteoporosis.
19 (9) Osteoporosis medications can be used to slow or stop
20 the breakdown of bone or assist in the growth of new bone.
21 (10) Nutritional supplements, increasing exercise and
22 strength training may also be helpful in reducing the effects
23 of osteoporosis and alleviating issues with bone density and
24 muscle pain.
25 Section 3. Legislative purpose.
26 The purpose of this act is to provide coverage for
27 preventative measures, screenings and treatments for
28 osteoporosis beginning before or at the onset of menopause.
29 Section 4. Definitions.
30 The following words and phrases when used in this act shall
20250HB1827PN2252 - 2 -
1 have the meanings given to them in this section unless the
2 context clearly indicates otherwise:
3 "Bone mineral density testing." An imaging test that
4 measures the amount of mineral in a certain volume of bone,
5 which is an indirect indicator of bone strength.
6 "Cost-sharing." The following:
7 (1) The share of the health care costs covered by a
8 health insurance policy that an enrollee or covered person
9 pays out of pocket.
10 (2) The term includes a deductible, coinsurance,
11 copayment or similar charge.
12 (3) The term does not include a premium, a balance
13 billed amount from an out-of-network provider or the cost of
14 a noncovered service.
15 "Department." The Department of Human Services of the
16 Commonwealth.
17 "Dietary supplement." A dietary supplement prescribed for
18 the maintenance or promotion of bone health.
19 "Health insurance policy." As defined in section 2102 of the
20 act of May 17, 1921 (P.L.682, No.284), known as The Insurance
21 Company Law of 1921.
22 "Menopause." The cessation of menstrual periods for 12
23 consecutive months, which can occur by a natural process of the
24 body or can be caused medically or surgically and may be
25 accompanied by any of the following symptoms:
26 (1) Irregular menstrual periods.
27 (2) Hot flashes.
28 (3) Vaginal or bladder problems.
29 (4) Decrease in fertility.
30 (5) Loss of bone density, including osteoporosis.
20250HB1827PN2252 - 3 -
1 (6) Elevated low-density lipoprotein cholesterol levels.
2 (7) Sleep disruption, including night sweats.
3 "Osteoporosis." A disease characterized by loss of bone mass
4 or structural deterioration, causing a decrease in bone strength
5 and an increased risk of fractures.
6 Section 5. Duties of department.
7 (a) Medical assistance coverage.--Subject to Federal
8 approval, the department shall provide medical assistance
9 coverage for screenings and treatments for osteoporosis for
10 eligible and enrolled medical assistance recipients who have
11 reached menopause. The coverage required under this section
12 shall, at a minimum, include:
13 (1) Coverage for bone mineral density testing.
14 (2) Coverage for hormonal and nonhormonal treatments
15 used to treat menopausal symptoms, including osteoporosis.
16 (3) Coverage for all drugs, devices and combination
17 products approved by the United States Food and Drug
18 Administration for the prevention or treatment of
19 osteoporosis.
20 (b) State plan amendment or Federal waiver.--The department
21 shall seek a State plan amendment or Federal waiver from the
22 Centers for Medicare and Medicaid Services, if needed, for the
23 provision of the services listed in this section under the
24 medical assistance program.
25 Section 6. Duties of insurers.
26 (a) Coverage requirement.--A health insurance policy
27 offered, issued or renewed in this Commonwealth shall provide
28 coverage of preventative measures, testing and treatments for
29 osteoporosis for covered individuals who have reached menopause.
30 The coverage required under this section shall, at a minimum,
20250HB1827PN2252 - 4 -
1 include:
2 (1) Coverage for bone mineral density testing.
3 (2) Coverage or reimbursement for preventative measures,
4 including:
5 (i) Dietary supplements.
6 (ii) Weight training or personal training services.
7 (iii) Physical therapy.
8 (3) Coverage for hormonal and nonhormonal treatments
9 used to treat menopausal symptoms, including osteoporosis.
10 (4) Coverage for all drugs, devices and combination
11 products approved by the United States Food and Drug
12 Administration for the prevention or treatment of
13 osteoporosis.
14 (b) Terms and conditions.--The coverage required under this
15 section shall be subject to the terms and conditions of a health
16 insurance policy, including provisions relating to medical
17 necessity, cost-sharing and utilization review.
18 (c) Condition.--Coverage may be conditioned upon the covered
19 individual receiving a prescription for the items under
20 subsection (a)(2).
21 Section 7. Applicability.
22 This act shall apply as follows:
23 (1) For a health insurance policy for which either rates
24 or forms are required to be filed with the Insurance
25 Department, this act shall apply to a policy for which a form
26 or rate is first filed on or after the effective date of this
27 paragraph.
28 (2) For a health insurance policy for which neither
29 rates nor forms are required to be filed with the Insurance
30 Department, this act shall apply to a policy issued or
20250HB1827PN2252 - 5 -
1 renewed on or after 180 days after the effective date of this
2 paragraph.
3 Section 8. Effective date.
4 This act shall take effect in 90 days.
20250HB1827PN2252 - 6 -Connected on the graph
Outbound (1)
| date | type | to | amount | role | source |
|---|---|---|---|---|---|
| — | referred_to_committee | Pennsylvania House Insurance Committee | — | pa-leg |
The full graph
Every typed relationship touching this entity — 1 edge across 1 category. Grouped by what the connection is; the heaviest few are shown, with a link to the full list.
Committees
→ Referred to committee 1 edge
Who matters
Members ranked by combined influence on this bill: role (sponsor 5 / cosponsor 1), capped speech count from the Congressional Record, and recorded-vote engagement.
| # | Member | Role | Speeches | Voted | Score |
|---|---|---|---|---|---|
| 1 | Melissa L. Shusterman (D, state_lower PA-157) | sponsor | 0 | — | 5 |
| 2 | Benjamin V. Sanchez (D, state_lower PA-153) | cosponsor | 0 | — | 1 |
| 3 | Carol Hill-Evans (D, state_lower PA-95) | cosponsor | 0 | — | 1 |
| 4 | Darisha K. Parker (D, state_lower PA-198) | cosponsor | 0 | — | 1 |
| 5 | Kristine C. Howard (D, state_lower PA-167) | cosponsor | 0 | — | 1 |
| 6 | Liz Hanbidge (D, state_lower PA-61) | cosponsor | 0 | — | 1 |
| 7 | Nancy Guenst (D, state_lower PA-152) | cosponsor | 0 | — | 1 |
| 8 | Nikki Rivera (D, state_lower PA-96) | cosponsor | 0 | — | 1 |
| 9 | Pat Gallagher (D, state_lower PA-173) | cosponsor | 0 | — | 1 |
Predicted vote
Aggregated from: actual roll-call votes (when present) → sponsor → cosponsor → party median (predicts YES when ≥25% of the caucus sponsored/cosponsored). Each row labels its confidence tier so you can see why a position was predicted.
0 predicted yes (0%) · 543 predicted no (100%) · 0 unknown (0%)
By party: · R: 0 yes / 277 no · D: 0 yes / 263 no · I: 0 yes / 3 no
Activity
Every typed-graph event involving this entity, newest first. Each row is one edge in the influence graph; click the date to jump to its provenance.
- 2026-05-20 · was referred to Pennsylvania House Insurance Committee · pa-leg